• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双功能二脱水半乳糖醇对DNA烷基化位点的体内研究

In vivo study on alkylation site in DNA by the bifunctional dianhydrogalactitol.

作者信息

Institoris E

出版信息

Chem Biol Interact. 1981 May;35(2):207-16. doi: 10.1016/0009-2797(81)90144-7.

DOI:10.1016/0009-2797(81)90144-7
PMID:7214602
Abstract

In vivo alkylation of Yoshida sarcoma cell DNA by 3H-labelled 1,2:5,6-dianhydrogalactitol (DAG) yielded N-7 monogalactitylguanines and 1,6-di-(guanin-7-yl)-galactitol, similar to the alkylated products obtained by in vitro reaction of DNA with dianhydrogalactitol in neutral solution. The ratio between monoalkylguanines and diguaninyl product was 2-2.5, slightly increasing with doses. Persistence of alkylated products in DNA was followed in function of time. There was no significant loss of either monoalkylated bases or diguaninyl derivative during the observation period i.e. 7-24 h after treatment. In contrast, the physical measurements of the amount of renaturable DNA showed a rapid opening of cross-links in the same period. Taking the presence of diguaninyl moiety as an indicator of cross-links in DNA, these two latter findings show an apparent contradiction which could be reconciled however by the mechanism proposed by Reid and Walker (Biochim. Biophys. Acta, 179 (1969) 179) for the removal of cross-linkage induced by HN2. Accordingly, one arm of the cross-links is removed, probably enzymically, leaving the DNA non-renaturable, while the other arm of cross-link is still covalently attached to the DNA molecule rendering possible the detection of diguaninyl moiety in DNA at some later time. This concept for the removal of cross-links from DNA seems to be supported by our results too.

摘要

用³H标记的1,2:5,6 - 二脱水半乳糖醇(DAG)对吉田肉瘤细胞DNA进行体内烷基化反应,产生了N - 7单半乳糖基鸟嘌呤和1,6 - 二 -(鸟嘌呤 - 7 - 基)- 半乳糖醇,这与DNA在中性溶液中与二脱水半乳糖醇进行体外反应所得到的烷基化产物相似。单烷基鸟嘌呤与双鸟嘌呤基产物之间的比例为2 - 2.5,随剂量略有增加。随着时间的推移追踪了DNA中烷基化产物的持久性。在观察期内,即处理后7 - 24小时,单烷基化碱基或双鸟嘌呤基衍生物均无明显损失。相比之下,对可复性DNA量的物理测量表明,在同一时期交联迅速打开。以后者双鸟嘌呤基部分的存在作为DNA中交联的指标,这后两个发现显示出明显的矛盾,然而通过Reid和Walker(《生物化学与生物物理学报》,179 (1969) 179)提出的关于去除由HN2诱导的交联的机制可以得到解释。因此,交联的一个臂可能通过酶促作用被去除,使DNA不可复性,而交联的另一个臂仍共价连接在DNA分子上,使得在稍后的某个时间能够检测到DNA中的双鸟嘌呤基部分。从DNA中去除交联的这一概念似乎也得到了我们结果的支持。

相似文献

1
In vivo study on alkylation site in DNA by the bifunctional dianhydrogalactitol.双功能二脱水半乳糖醇对DNA烷基化位点的体内研究
Chem Biol Interact. 1981 May;35(2):207-16. doi: 10.1016/0009-2797(81)90144-7.
2
Alkylation by 1,2:5,6-dianhydrogalactitol of deoxyribonucleic acid and guanosine.1,2:5,6-二脱水半乳糖醇对脱氧核糖核酸和鸟苷的烷基化作用。
Biochem J. 1980 Mar 1;185(3):659-66. doi: 10.1042/bj1850659.
3
The interaction of dianhydrogalactitol with DNA in cultured Yoshida sarcoma cells.双脱水半乳糖醇与培养的吉田肉瘤细胞中DNA的相互作用。
Chem Biol Interact. 1978 Jul;22(1):99-107. doi: 10.1016/0009-2797(78)90153-9.
4
Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol.两种烷化剂之间不存在交叉耐药性:卡莫司汀与双功能半乳糖醇。
Cancer Chemother Pharmacol. 1989;24(5):311-3. doi: 10.1007/BF00304764.
5
Interaction of GGCC sequences of DNA with anticancer dianhydrogalacticol, detected by inhibition of restriction enzyme BspI.
Acta Biochim Biophys Acad Sci Hung. 1984;19(3-4):177-84.
6
Pharmacokinetics and metabolism of dianhydrogalactitol DAG in patients: a comparison with the human disposition of dibromodulcitol DBD.患者中双脱水半乳糖醇(DAG)的药代动力学与代谢:与二溴卫矛醇(DBD)在人体内处置情况的比较。
Eur J Cancer Clin Oncol. 1986 Feb;22(2):163-71. doi: 10.1016/0277-5379(86)90026-x.
7
Pharmacokinetic study in a phase I trial with an alkylating agent, diacetyldianhydrogalactitol (DADAG).一项关于烷化剂双乙酰双去水半乳糖醇(DADAG)的I期试验的药代动力学研究。
Cancer Chemother Pharmacol. 1986;16(3):257-63. doi: 10.1007/BF00293988.
8
Identification of guanine and adenine adducts in DNA alkylated by dibromodulcitol in vitro and in vivo.
Chem Biol Interact. 1983 Nov;47(2):133-44. doi: 10.1016/0009-2797(83)90153-9.
9
The interaction of bifunctional alkylating agents with the DNA of tumour cells.双功能烷化剂与肿瘤细胞DNA的相互作用。
Eur J Cancer (1965). 1976 Jan;12(1):53-9. doi: 10.1016/0014-2964(76)90124-9.
10
Chemotherapeutic approaches to brain tumors. Experimental observations with dianhydrogalactitol and dibromodulcitol.脑肿瘤的化疗方法。双脱水半乳糖醇和二溴卫矛醇的实验观察
Cancer Chemother Pharmacol. 1982;8(1):125-31. doi: 10.1007/BF00292883.

引用本文的文献

1
Dianhydrogalactitol induces replication-dependent DNA damage in tumor cells preferentially resolved by homologous recombination.二羟甘露醇诱导肿瘤细胞中依赖复制的 DNA 损伤,这些损伤可被同源重组优先修复。
Cell Death Dis. 2018 Oct 3;9(10):1016. doi: 10.1038/s41419-018-1069-9.
2
1,2:5,6-dianhydrogalactitol inhibits human glioma cell growth in vivo and in vitro by arresting the cell cycle at G/M phase.1,2:5,6-二去水半乳糖醇通过将细胞周期阻滞在G/M期来抑制人胶质瘤细胞在体内和体外的生长。
Acta Pharmacol Sin. 2017 Apr;38(4):561-570. doi: 10.1038/aps.2016.154. Epub 2017 Feb 20.
3
Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol.
两种烷化剂之间不存在交叉耐药性:卡莫司汀与双功能半乳糖醇。
Cancer Chemother Pharmacol. 1989;24(5):311-3. doi: 10.1007/BF00304764.
4
Benzamide potentiation of the cytotoxicity of bifunctional galactitol [correction of galacticol] in resistant P388 leukemia correlates with inhibition of DNA ligase II.苯甲酰胺增强双功能半乳糖醇(纠正:半乳糖醇)对耐药P388白血病细胞的细胞毒性作用与DNA连接酶II的抑制相关。
Cancer Chemother Pharmacol. 1992;30(4):325-9. doi: 10.1007/BF00686304.